$0.55 EPS Expected for Endo International plc (ENDP) on May, 8

April 16, 2018 - By Patrick Harkless

Endo International plc (NASDAQ:ENDP) Corporate Logo
Big Money Sentiment increased to 1.13 in Q4 2017. It has change of 0.01, from 2017Q3’s 1.12. The ratio increased due to Endo International plc positioning: 37 sold and 61 reduced. 39 funds amassed positions and 72 increased positions. Investors holded 202.81 million in 2017Q3 but now own 203.77 million shares or 0.47% more.
Ajo L P has invested 0.04% in Endo International plc (NASDAQ:ENDP). Piedmont Invest Advisors Limited Liability Com has invested 0.01% in Endo International plc (NASDAQ:ENDP). Oakbrook Investments Lc reported 0.01% in Endo International plc (NASDAQ:ENDP). Pointstate Lp reported 0.01% in Endo International plc (NASDAQ:ENDP). 41,855 were reported by Public Employees Retirement Association Of Colorado. Systematic Fin Limited Partnership has invested 0.03% of its capital in Endo International plc (NASDAQ:ENDP). 1832 Asset Mgmt L P invested 0% of its capital in Endo International plc (NASDAQ:ENDP). Macquarie Gru Incorporated Ltd stated it has 0% of its capital in Endo International plc (NASDAQ:ENDP). Tekla Mgmt Llc holds 914,548 shs or 0.27% of its capital. Bluemountain Capital Mgmt Lc holds 0.03% or 179,459 shs. Renaissance Technology Limited Liability Corporation holds 0.06% or 6.74 million shs. Chicago Equity Prtnrs Ltd invested 0.1% of its capital in Endo International plc (NASDAQ:ENDP). Dimensional Fund Advsr Lp, Texas-based fund reported 10.12M shs. Amundi Pioneer Asset Mgmt holds 96,033 shs. Orbimed Advsrs Ltd Co reported 1.02 million shs.

Endo International plc (NASDAQ:ENDP)’s earnings report is anticipated On May, 8., Zacks reports. Analysts have expectation on stock’s earnings per share of $0.55. That’s down 55.28 % from last year’s $1.23 earnings per share. ENDP’s profit could reach $122.79M with 2.48 P/E in case $0.55 earnings per share is published. After $0.77 EPS report last quarter, Wall Street now predicts -28.57 % negative EPS growth of Endo International plc. On during the last trading session the stock decreased $0.02 or 0.36%, reaching $5.46.Endo International plc has volume of 3.46M shares. Since April 17, 2017 ENDP has declined 44.86% and is downtrending. ENDP underperformed by 56.41% the S&P500.

Endo International plc (NASDAQ:ENDP) Ratings Coverage

In total 16 analysts cover Endo International (NASDAQ:ENDP). “Buy” rating has 2, “Sell” are 0, while 14 are “Hold”. 13% are bullish. 23 are the (NASDAQ:ENDP)’s analyst reports since October 17, 2017 according to StockzIntelligence Inc. In Thursday, November 9 report Cowen & Co maintained the stock with “Hold” rating. On Thursday, November 9 the firm earned “Hold” rating by Piper Jaffray. The company rating was downgraded by Gabelli on Wednesday, February 28. On Wednesday, April 4 the stock of Endo International plc (NASDAQ:ENDP) has “Neutral” rating given by Mizuho. In Friday, February 23 report Barclays Capital maintained the stock with “Equal-Weight” rating. On Sunday, November 12 the rating was maintained by Canaccord Genuity with “Hold”. On Wednesday, February 28 William Blair maintained Endo International plc (NASDAQ:ENDP) with “Hold” rating. On Monday, October 30 the firm has “Hold” rating by BMO Capital Markets given. On Tuesday, October 17 the rating was maintained by RBC Capital Markets with “Hold”. On Wednesday, February 21 Canaccord Genuity maintained Endo International plc (NASDAQ:ENDP) with “Hold” rating.

Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide.The firm is worth $1.22 billion. The Company’s U.S.Currently it has negative earnings. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets.

Endo International plc (NASDAQ:ENDP) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.